Colorectal chemoprevention pilot study (SWOG-9041), randomized and placebo controlled

The importance of multiple luminal lesions

David Z J Chu, Michael A. Hussey, David S. Alberts, Frank L. Meyskens, Cecilia M. Fenoglio-Preiser, Saul E. Rivkin, Glenn M. Mills, Jeffrey K. Giguere, Charles Blanke, Gary E. Goodman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Colorectal cancer is common worldwide and chemoprevention has the potential of reducing the number of individuals who may suffer and perish from this disease. Methods: A randomized placebo controlled pilot study in colorectal cancer patients was performed using calcium carbonate as the test agent in a multi-institutional oncology study group. Results: Two hundred twenty volunteers were randomized in the study. The primary goals of compliance, accrual, and toxicity monitoring are presented. Presence of multiple adenomas at study entry and subsequent development of metachronous adenomas were recorded and found to be associated with synchronous adenomas. The secondary endpoint of recurrent adenomas indicated lower rates of new adenoma in the volunteers randomized to the calcium group. Conclusion: This pilot study indicates the feasibility of enrolling survivors of colorectal cancer as study volunteers in a colorectal neoplasm chemoprevention clinical trial and oral calcium continues to be a potentially effective drug in reducing colorectal adenomas.

Original languageEnglish (US)
Pages (from-to)310-316
Number of pages7
JournalClinical Colorectal Cancer
Volume10
Issue number4
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Chemoprevention
Adenoma
Placebos
Colorectal Neoplasms
Volunteers
Calcium
Calcium Carbonate
Compliance
Survivors
Clinical Trials
Pharmaceutical Preparations

Keywords

  • Calcium carbonate
  • Metachronous adenomas
  • Synchronous adenomas

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Chu, D. Z. J., Hussey, M. A., Alberts, D. S., Meyskens, F. L., Fenoglio-Preiser, C. M., Rivkin, S. E., ... Goodman, G. E. (2011). Colorectal chemoprevention pilot study (SWOG-9041), randomized and placebo controlled: The importance of multiple luminal lesions. Clinical Colorectal Cancer, 10(4), 310-316. https://doi.org/10.1016/j.clcc.2011.06.005

Colorectal chemoprevention pilot study (SWOG-9041), randomized and placebo controlled : The importance of multiple luminal lesions. / Chu, David Z J; Hussey, Michael A.; Alberts, David S.; Meyskens, Frank L.; Fenoglio-Preiser, Cecilia M.; Rivkin, Saul E.; Mills, Glenn M.; Giguere, Jeffrey K.; Blanke, Charles; Goodman, Gary E.

In: Clinical Colorectal Cancer, Vol. 10, No. 4, 2011, p. 310-316.

Research output: Contribution to journalArticle

Chu, DZJ, Hussey, MA, Alberts, DS, Meyskens, FL, Fenoglio-Preiser, CM, Rivkin, SE, Mills, GM, Giguere, JK, Blanke, C & Goodman, GE 2011, 'Colorectal chemoprevention pilot study (SWOG-9041), randomized and placebo controlled: The importance of multiple luminal lesions', Clinical Colorectal Cancer, vol. 10, no. 4, pp. 310-316. https://doi.org/10.1016/j.clcc.2011.06.005
Chu, David Z J ; Hussey, Michael A. ; Alberts, David S. ; Meyskens, Frank L. ; Fenoglio-Preiser, Cecilia M. ; Rivkin, Saul E. ; Mills, Glenn M. ; Giguere, Jeffrey K. ; Blanke, Charles ; Goodman, Gary E. / Colorectal chemoprevention pilot study (SWOG-9041), randomized and placebo controlled : The importance of multiple luminal lesions. In: Clinical Colorectal Cancer. 2011 ; Vol. 10, No. 4. pp. 310-316.
@article{8f9047877a3d418f9ee8e5647eb9b0b0,
title = "Colorectal chemoprevention pilot study (SWOG-9041), randomized and placebo controlled: The importance of multiple luminal lesions",
abstract = "Background: Colorectal cancer is common worldwide and chemoprevention has the potential of reducing the number of individuals who may suffer and perish from this disease. Methods: A randomized placebo controlled pilot study in colorectal cancer patients was performed using calcium carbonate as the test agent in a multi-institutional oncology study group. Results: Two hundred twenty volunteers were randomized in the study. The primary goals of compliance, accrual, and toxicity monitoring are presented. Presence of multiple adenomas at study entry and subsequent development of metachronous adenomas were recorded and found to be associated with synchronous adenomas. The secondary endpoint of recurrent adenomas indicated lower rates of new adenoma in the volunteers randomized to the calcium group. Conclusion: This pilot study indicates the feasibility of enrolling survivors of colorectal cancer as study volunteers in a colorectal neoplasm chemoprevention clinical trial and oral calcium continues to be a potentially effective drug in reducing colorectal adenomas.",
keywords = "Calcium carbonate, Metachronous adenomas, Synchronous adenomas",
author = "Chu, {David Z J} and Hussey, {Michael A.} and Alberts, {David S.} and Meyskens, {Frank L.} and Fenoglio-Preiser, {Cecilia M.} and Rivkin, {Saul E.} and Mills, {Glenn M.} and Giguere, {Jeffrey K.} and Charles Blanke and Goodman, {Gary E.}",
year = "2011",
doi = "10.1016/j.clcc.2011.06.005",
language = "English (US)",
volume = "10",
pages = "310--316",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Colorectal chemoprevention pilot study (SWOG-9041), randomized and placebo controlled

T2 - The importance of multiple luminal lesions

AU - Chu, David Z J

AU - Hussey, Michael A.

AU - Alberts, David S.

AU - Meyskens, Frank L.

AU - Fenoglio-Preiser, Cecilia M.

AU - Rivkin, Saul E.

AU - Mills, Glenn M.

AU - Giguere, Jeffrey K.

AU - Blanke, Charles

AU - Goodman, Gary E.

PY - 2011

Y1 - 2011

N2 - Background: Colorectal cancer is common worldwide and chemoprevention has the potential of reducing the number of individuals who may suffer and perish from this disease. Methods: A randomized placebo controlled pilot study in colorectal cancer patients was performed using calcium carbonate as the test agent in a multi-institutional oncology study group. Results: Two hundred twenty volunteers were randomized in the study. The primary goals of compliance, accrual, and toxicity monitoring are presented. Presence of multiple adenomas at study entry and subsequent development of metachronous adenomas were recorded and found to be associated with synchronous adenomas. The secondary endpoint of recurrent adenomas indicated lower rates of new adenoma in the volunteers randomized to the calcium group. Conclusion: This pilot study indicates the feasibility of enrolling survivors of colorectal cancer as study volunteers in a colorectal neoplasm chemoprevention clinical trial and oral calcium continues to be a potentially effective drug in reducing colorectal adenomas.

AB - Background: Colorectal cancer is common worldwide and chemoprevention has the potential of reducing the number of individuals who may suffer and perish from this disease. Methods: A randomized placebo controlled pilot study in colorectal cancer patients was performed using calcium carbonate as the test agent in a multi-institutional oncology study group. Results: Two hundred twenty volunteers were randomized in the study. The primary goals of compliance, accrual, and toxicity monitoring are presented. Presence of multiple adenomas at study entry and subsequent development of metachronous adenomas were recorded and found to be associated with synchronous adenomas. The secondary endpoint of recurrent adenomas indicated lower rates of new adenoma in the volunteers randomized to the calcium group. Conclusion: This pilot study indicates the feasibility of enrolling survivors of colorectal cancer as study volunteers in a colorectal neoplasm chemoprevention clinical trial and oral calcium continues to be a potentially effective drug in reducing colorectal adenomas.

KW - Calcium carbonate

KW - Metachronous adenomas

KW - Synchronous adenomas

UR - http://www.scopus.com/inward/record.url?scp=84855965299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855965299&partnerID=8YFLogxK

U2 - 10.1016/j.clcc.2011.06.005

DO - 10.1016/j.clcc.2011.06.005

M3 - Article

VL - 10

SP - 310

EP - 316

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 4

ER -